Tests cromoglicate added to usual care for schizophrenia and schizoaffective disorder
Tests cromoglicate alongside usual treatment in adults with schizophrenia or schizoaffective disorder.
Plain-language title generated from the registry record
Registry title: Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia
Key facts
- Where
- Pittsburgh, United StatesSee the site
- Phase
- Phase 1/2
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT03794076, who can take part
Where in United States
- University of PittsburghPittsburgh, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Vishwajit Nimgaonkar, MD PhD
- Trial code
- NCT03794076
- Record updated
- 19 March 2026
- Original description
This is a double blind adjunctive randomized controlled trial for schizophrenia using cromoglicate.Read full original descriptionShow less
Cromoglicte Adjunctive Therapy for Outpatients With Schizophrenia
This is a double blind adjunctive randomized controlled trial for schizophrenia using cromoglicate.
Inclusion: Written informed consent; Both genders, ages 18-60 years; Schizophrenia / schizoaffective disorder (DSM V); Treated with the same APD for at least 60 days; Stable dose of APD for > 1 month, continued throughout the study; PANSS total score of 60 and Score 4 or more on one or more items of the 'positive' syndrome items (P1-P7); Preference for patients with duration of psychosis less than 7 years.
Exclusion: History of immune disorders, HIV infection, or receiving immune-suppressants or immuno-modulators, e.g., steroids; Current or prior treatment with CGY or History of hypersensitivity to CGY; History or current medical /neurological illnesses that may lead to an unstable course with the exception of epilepsy which is well-controlled on an antiepileptic medication for at least 6 months; No illicit substance use in last 30 days/no dependence in 6 months with the exception of methadone treatment for opioid withdrawal; Pregnancy; Intellectual disability as defined in DSM V.